Experimental neurotrophic factor therapy leads to cortical synaptic remodeling and compensates for behavioral deficits

Journal of Psychiatry and Neuroscience

Volumn 22, Issue 1, 1997, Pages 46-55

  Cuello, A Claudio ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

behavior; cholinergic system; cortical synapses; neural regeneration; neurotrophic factors; synaptogenesis

Indexed keywords

NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; FOREBRAIN; NEOCORTEX; NERVE CELL; NONHUMAN; PHENOTYPE; RAT; REVIEW; SYNAPSE;

ANIMALS; ATROPHY; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CEREBRAL INFARCTION; NERVE GROWTH FACTORS; NERVE REGENERATION; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEURONAL PLASTICITY; PHENOTYPE; RATS; RNA, MESSENGER; SYNAPSES;

EID: 0031051064     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Anderson KD, Alderson RF, Altar CA, DiStefano PS, Corcoran TL, Lindsay RM, Wiegand SJ. 1995. Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors. J Comp Neurol 357:296-317.
2. Anderson KJ, Dam D, Lee S, Cotman CW. 1988. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature 332:360-2.
3. Bartus RT, Dean RL, Beer B, Lippa AS. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-17.
4. Berardi N, Cellerino A, Domenici L, Fagiolini M, Pizzorusso T, Cattaneo A, Maffei L. 1994. Monoclonal antibodies to nerve growth factor affect the postnatal development of the visual system. Proc Natl Acad Sci U S A 91:684-8.
5. Bowen DM, Smith CB, White P, Davison AN. 1976. Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459-96.
6. Burgos I, Cuello AC, Liberini P, Pioro EP, Masliah E. 1995. NGF-mediated synaptic sprouting in the cerebral cortex of lesioned primate brain. Brain Res 692:154-60.
7. Cabelli RJ, Hohn A, Shatz CJ. 1995. Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF. Science 267:1662-6.
8. Chen KS, Masliah E, Mallory M, Gage FE. 1995. Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion. Neuroscience 68:19-27.
9. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, McMahon SB, Shelton DL, Levinson AD, and others. 1994. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76:1001-11.
10. Cuello AC. 1994. Trophic factor therapy in the adult CNS: remodelling of injured basalo-cortical neurons. Prog Brain Res 100:213-21.
11. Cuello AC, Garofalo L, Kenigsberg RL, Maysinger D. 1989. Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons. Proc Natl Acad Sci U S A 86:2056-60.
12. Cuello AC, Thoenen H. 1995. The pharmacology of neurotrophic factors. In: Cuello AC, Collier B, editors. Pharmacological sciences: perspectives for research and training in the late 1990s. Basel: Birkhauser. p 241-5.
13. Davies P, Maloney A. 1976. A selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
14. DeKosky ST, Scheff SW. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27:457-64.
15. Durbec P, Marcosgutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, and others. 1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature 381:789-93.
16. Elliott PJ, Garofalo L, Cuello AC. 1989. Limited neocortical devascularizing lesions causing deficits in memory retention and choline acetyltransferase activity - effects of the monosialoganglioside GM1. Neuroscience 31:63-76.
17. Emfors P, Lee KF, Kucera J, Jaenisch R. 1994. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 77:503-12.
18. Figueiredo BC, Piccardo P, Maysinger D, Clarke PBS, Cuello AC. 1993. Effects of acidic fibroblast growth factor on cholinergic neurons of nucleus basalis magnocellularis and in a spatial memory task following cortical devascularization. Neuroscience 56:955-63.
19. Figueiredo BC, Pluss K, Skup M, Otten U, Cuello AC. 1995a. Acidic FGF induces and its mRNA in the injured neocortex of adult animals. Mol Brain Res 33:1-6.
20. NGFR and GAP-43 genes in nucleus basalis magnocellularis, thalamus and adjacent cortex following neocortical infarction and NGF treatment. Neuroscience 68:29-45.
21. Fischer W, Wictorin K, Björklund A, Williams L, Varon S, Gage FH. 1987. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329:65-8.
22. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, and others. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 37:3523-7.
23. Garofalo L. 1993. Nerve growth factor-and/or monosialoganglioside GM1-induced neuroplasticity in brain of decorticated adult and aged rats [dissertation]. Montreal: McGill University. 369 p.
24. Garofalo L, Cuello AC. 1994. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats. Exp Neurol 125:195-217.
25. Garofalo L, Cuello AC. 1995. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain. J Pharmacol Exp Ther 272:527-45.
26. Garofalo L, Ribeiro-da-Silva A, Cuello AC. 1992. Nerve growth factor-induced synaptogenesis and hypertrophy of cortical cholinergic terminals. Proc Natl Acad Sci U S A 89:2639-43.
27. Garofalo L, Ribeiro-da-Silva A, Cuello AC. 1993. Potentiation of nerve growth factor-induced alterations in cholinergic fibre length and presynaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1. Neuroscience 57:21-40.
28. Gibbs RB, Pfaff DW. 1994. In situ hybridization detection of trkA mRNA in brain: distribution, colocalization with p75NGFR and up-regulation by nerve growth factor. J Comp Neurol 341:324-39.
29. Giehl KM, Tetzlaff W. 1996. BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo. Eur J Neurosci 8:1167-75.
30. Hagg T, Manthorpe M, Vahlsing HL, Varon S. 1988. Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage. Exp Neurol 101:303-12.
31. Hefti F. 1986. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6:2155-62.
32. Kawaja MD, Rosenberg MB, Yoshida K, Gage FH. 1992. Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J Neurosci 12:2849-64.
33. Klein R, Silos-Santiago I, Smeyne RJ, Lira SA, Brambilla R, Bryant S, Zhang L, Snider WD, Barbacid M. 1994. Disruption of the neurotrophin-3 receptor gene trkC eliminates 1a muscle afferents and results in abnormal movements. Nature 368:249-51.
34. Klein R, Smeyne RJ, Wurst W, Long LK, Auerbach BA, Joyner AL, Barbacid M. 1993. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75:113-22.
35. Knipper M, Leung LS, Zhao D, Rylett RJ. 1994. Short-term modulation of glutamatergic synapses in adult rat hippocampus by NGF. Neuroreport 5:2433-6.
36. Kolb B, Côté S, Ribeiro-da-Silva A, Cuello AC. 1997. NGF treatment prevents dendritic atrophy and promotes recovery of function after cortical injury. Neuroscience. Forthcoming.
37. Korsching S, Auburger G, Heumann R, Scott J, Thoenen H. 1985. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J 4:1389-93.
38. 3H]acetylcholine release and choline acetyltransferase activity. Neuroscience 42:639-49.
39. LeSauteur L, Wei L, Gibbs BF, Saragovi HU. 1995. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem 270:6564-9.
40. Lewin GR, Barde Y-A. 1996. Physiology of the neurotrophins. In: Cowan WM, Shooter EM, Stevens CF, Thompson RF, editors. Annual review of neuroscience. Palo Alto: Annual Reviews Inc. p 289-317.
41. Lewin GR, Mendell LM. 1993. Nerve growth factor and nociception. Trends Neurosci 16:353-9.
42. Liberini P, Cuello AC. 1994. Effects of nerve growth factor in primate models of neurodegeneration: potential relevance in clinical neurology. Rev Neurosci 5:89-104.
43. Liberini P, Pioro EP, Maysinger D, Cuello AC. 1994. Neocortical infarction in subhuman primates leads to restricted morphological damage of the cholinergic neurons in the nucleus basalis of Meynert. Brain Res 648:1-8.
44. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS. 1994. Neurotrophic factors: from molecule to man. Trends Neurosci 17:182-90.
45. Lucidi-Phillipi CA, Gage FH. 1993. The neurotrophic hypothesis and the cholinergic basal forebrain projection. In: Cuello AC, editor. Cholinergic function and dysfunction. Amsterdam: Elsevier. p 241-50.
46. Ma W, Ribeiro-da-Silva A, Noel G, Julien J-P, Cuello AC. 1995. Ectopic substance P and calcitonin gene-related peptide immunoreactive fibers in the spinal cord of transgenic mice over-expressing nerve growth factor. Eur J Neurosci 7:2021-35.
47. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA. 1991. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease. Am J Pathol 138:235-46.
48. Maysinger D, Herrera-Marschitz M, Goiny M, Ungerstedt U, Cuello AC. 1992. Effects of nerve growth factor on cortical and striatal acetylcholine and dopamine release in rats with cortical devascularizing lesions. Brain Res 577:300-5.
49. McMahon SB, Bennett DLH, Priestley JV, Shelton DL. 1995. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nature Med 1:774-80.
50. McMahon SB, Priestley J-V. 1995. Peripheral neuropathies and neurotrophic factors: animal models and clinical perspectives. Curr Opin Neurobiol 5:616-24.
51. Mervis RF, Pope D, Lewis R, Dvorak RM, Williams LR. 1991. Exogenous nerve growth factor reverses age-related structural changes in neocortical neurons in the aging rat: a quantitative Golgi study. Ann N Y Acad Sci 640:95-101.
52. Muragaki Y, Timothy N, Leight S, Hempstead BL, Chao MV, Trojanowski JQ, Lee VM. 1995. Expression of trk receptors in the developing and adult human central and peripheral nervous system. J Comp Neurol 356:387-97.
53. Pearson RC, Sofroniew MV, Cuello AC, Powell TP, Eckenstein F, Esiri MM, Wilcock GK. 1983. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 289:375-9.
54. Pierce JP, Lewin GR. 1994. An ultrastructural size principle. Neuroscience 58:441-6.
55. Pioro EP, Cuello AC. 1990. Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system: effect of colchicine and correlation with the cholinergic system - 1: forebrain. Neuroscience 24:57-87.
56. Pioro EP, Ribeiro-da-Silva A, Cuello AC. 1990. Immunoelectron microscopic evidence of nerve growth factor receptor metabolism and internalization in rat nucleus basalis neurons. Brain Res 527:109-15.
57. 125I] b-nerve growth factor. Neuroscience 20:23-36.
58. Richardson PM, Verge Issa VMK, Riopelle RJ. 1986. Distribution of neuronal receptors for nerve growth factor in the rat. J Neurosci 6:2312-21.
59. Rylett RJ, Goddard S, Schmidt BM, Williams LR. 1993. Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats. J Neurosci 13:3956-63.
60. Scali C, Casamenti F, Pazzagli M, Bartolini L, Pepeu G. 1994. Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. Neurosci Lett 170:117-20.
61. Schuman EM, Madison DV. 1994. Locally distributed synaptic potentiation in the hippocampus. Science 263:532-6.
62. Seiger Å, Nordberg A, Von Holst H, Bäckman L, Ebendal T, Alafuzoff I, Amberla K, Hartvig P, Herlitz A, Lilja A, and others. 1993. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav Brain Res 57:255-61.
63. Seiler M, Schwab ME. 1984. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res 300:34-9.
64. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barbacid M. 1994. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368:246-9.
65. Snider WD. 1994. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627-38.
66. Sobreviela T, Clary DO, Reichardt LF, Brandabur MM, Kordower JH, Mufson EJ. 1994. TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J Comp Neurol 350:587-611.
67. Sofroniew MV, Pearson RC, Eckenstein F, Cuello AC, Powell TP. 1983. Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage. Brain Res 289:370-4.
68. Sofroniew MV, Cooper JD, Svendsen CN, Crossman P, Ip NY, Lindsay RM, Zafra F, Lindholm D. 1993. Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3. J Neurosci 13:5263-76.
69. Springer JE, Koh B, Tavrien MN, Loy R. 1987. Basal forebrain magnocellular neurons stain for nerve growth factor receptor: correlation with cholinergic cell bodies and effects of axotomy. J Neurosci Res 17:111-8.
70. Steininger TL, Wainer BH, Klein R, Barbacid M, Palfrey HC. 1993. High-affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain. Brain Res 612:330-5.
71. Stephens PH, Cuello AC, Sofroniew MV, Pearson RC, Tagari P. 1985. Effect of unilateral decortication on choline acetyltransferase activity in the nucleus basalis and other areas of the rat brain. J Neurochem 45:1021-6.
72. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katznian R. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-80.
73. Thoenen H. 1995. Neurotrophins and neuronal plasticity. Science 270:593-8.
74. Treanor JJS, Goodman L, Desauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, and others. 1996. Characterization of a multicomponent receptor for GDNF. Nature 382:80-3.
75. Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA, Grigoriou M, Kilkenny C, Salazargrueso E, Pachnis V, Arumae U, and others. 1996. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381:785-9.
76. Vantini G, Schiavo N, DiMartino A, Polate P, Triban C, Callegro L, Toffano G, Leon A. 1989. Evidence for a physiological role of nerve growth factor in the central nervous system of neonatal rats. Neuron 3:267-73.
77. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-9.
78. Williams LR, Rylett RJ, Ingram DK, Joseph JA, Moises HC, Tang AH, Mervis RF. 1993. NGF affects the cholinergic biochemistry and behaviour of aged rats. Prog Brain Res 98:241-50.
79. Yoshida K, Gage FH. 1992. Cooperative regulation of nerve growth factor synthesis and secretion in fibroblasts and astrocytes by fibroblast growth factor and other cytokines. Brain Res 569:14-25.